102 related articles for article (PubMed ID: 10220258)
1. Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome.
Stroncek DF; Hubel A; Shankar RA; Burger SR; Pan D; McCullough J; Whitley CB
Transfusion; 1999 Apr; 39(4):343-50. PubMed ID: 10220258
[TBL] [Abstract][Full Text] [Related]
2. Combined ultrafiltration-transduction in a hollow-fiber bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II.
Pan D; Shankar R; Stroncek DF; Whitley CB
Hum Gene Ther; 1999 Nov; 10(17):2799-810. PubMed ID: 10584926
[TBL] [Abstract][Full Text] [Related]
3. Retroviral transduction of peripheral blood leukocytes in a hollow-fiber bioreactor.
Shankar R; Whitley CB; Pan D; Burger S; McCullough J; Stroncek D
Transfusion; 1997 Jul; 37(7):685-90. PubMed ID: 9225930
[TBL] [Abstract][Full Text] [Related]
4. "Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase.
Pan D; Jonsson JJ; Braun SE; McIvor RS; Whitley CB
Mol Genet Metab; 2000 Jul; 70(3):170-8. PubMed ID: 10924271
[TBL] [Abstract][Full Text] [Related]
5. Freezing characteristics of genetically modified lymphocytes for the treatment of MPS II.
Hubel A; Darr TB; Norman JA
Cell Transplant; 1999; 8(5):521-30. PubMed ID: 10580346
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II).
Braun SE; Pan D; Aronovich EL; Jonsson JJ; McIvor RS; Whitley CB
Hum Gene Ther; 1996 Feb; 7(3):283-90. PubMed ID: 8835216
[TBL] [Abstract][Full Text] [Related]
7. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
[TBL] [Abstract][Full Text] [Related]
8. Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase.
Braun SE; Aronovich EL; Anderson RA; Crotty PL; McIvor RS; Whitley CB
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11830-4. PubMed ID: 8265633
[TBL] [Abstract][Full Text] [Related]
9. Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II).
Whitley CB; McIvor RS; Aronovich EL; Berry SA; Blazar BR; Burger SR; Kersey JH; King RA; Faras AJ; Latchaw RE; McCullough J; Pan D; Ramsay NK; Stroncek DF
Hum Gene Ther; 1996 Mar; 7(4):537-49. PubMed ID: 8800749
[No Abstract] [Full Text] [Related]
10. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
[TBL] [Abstract][Full Text] [Related]
11. Mucopolysaccharidosis type II (Hunter's syndrome) in Taiwan.
Su PH; Hwu WL; Chiang SC; Chiu PC; Lin SJ; Shu SG; Wang TR
J Formos Med Assoc; 1998 Mar; 97(3):186-90. PubMed ID: 9549269
[TBL] [Abstract][Full Text] [Related]
12. Genetics and Gene Therapy in Hunter Disease.
Sestito S; Falvo F; Scozzafava C; Apa R; Pensabene L; Bonapace G; Moricca MT; Concolino D
Curr Gene Ther; 2018; 18(2):90-95. PubMed ID: 29618310
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II.
Wakabayashi T; Shimada Y; Akiyama K; Higuchi T; Fukuda T; Kobayashi H; Eto Y; Ida H; Ohashi T
Hum Gene Ther; 2015 Jun; 26(6):357-66. PubMed ID: 25761450
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy.
Jung SC; Park ES; Choi EN; Kim CH; Kim SJ; Jin DK
Mol Cells; 2010 Jul; 30(1):13-8. PubMed ID: 20652491
[TBL] [Abstract][Full Text] [Related]
16. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
[TBL] [Abstract][Full Text] [Related]
17. CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome).
Motas S; Haurigot V; Garcia M; Marcó S; Ribera A; Roca C; Sánchez X; Sánchez V; Molas M; Bertolin J; Maggioni L; León X; Ruberte J; Bosch F
JCI Insight; 2016 Jun; 1(9):e86696. PubMed ID: 27699273
[TBL] [Abstract][Full Text] [Related]
18. Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples.
Dean CJ; Bockmann MR; Hopwood JJ; Brooks DA; Meikle PJ
Clin Chem; 2006 Apr; 52(4):643-9. PubMed ID: 16497940
[TBL] [Abstract][Full Text] [Related]
19. In vitro correction of iduronate-2-sulfatase deficiency by adenovirus-mediated gene transfer.
Di Francesco C; Cracco C; Tomanin R; Picci L; Ventura L; Zacchello E; Di Natale P; Anson DS; Hopwood JJ; Graham FL; Scarpa M
Gene Ther; 1997 May; 4(5):442-8. PubMed ID: 9274721
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the Management of Mucopolysaccharidosis Type II (Hunter's Syndrome) in a Developing Country: a Case Report.
Rasheeedah I; Patrick O; Abdullateef A; Mohammed A; Sherifat K; Gbadebo I
Ethiop J Health Sci; 2015 Jul; 25(3):279-82. PubMed ID: 26633932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
